Naoki Haratake

2.3k total citations
106 papers, 1.7k citations indexed

About

Naoki Haratake is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Naoki Haratake has authored 106 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Pulmonary and Respiratory Medicine, 53 papers in Oncology and 23 papers in Surgery. Recurrent topics in Naoki Haratake's work include Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Diagnosis and Treatment (28 papers) and Cancer Immunotherapy and Biomarkers (24 papers). Naoki Haratake is often cited by papers focused on Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Diagnosis and Treatment (28 papers) and Cancer Immunotherapy and Biomarkers (24 papers). Naoki Haratake collaborates with scholars based in Japan, United States and Italy. Naoki Haratake's co-authors include Shinkichi Takamori, Gouji Toyokawa, Yoshihiko Maehara, Taichi Matsubara, Takaki Akamine, Yuka Kozuma, Tatsuro Okamoto, Fumihiro Shoji, Masakazu Katsura and Kazuki Takada and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Naoki Haratake

97 papers receiving 1.7k citations

Peers

Naoki Haratake

ONCOL

PRM

PHYSI

SURGE

Masakazu Katsura Japan

Takaki Akamine Japan

Taichi Matsubara Japan

Yuka Kozuma Japan

Shinkichi Takamori Japan

Takahiro Toyokawa Japan

Inkeun Park South Korea

Kenei Furukawa Japan

Hiroyuki Fujikawa Japan

Ryosuke Amano Japan

Masakazu Katsura Japan

Naoki Haratake

872 ×0.8

ONCOL

641 ×0.7

PRM

316 ×1.3

PHYSI

218 ×0.9

SURGE

154 ×0.7

Citations per year, relative to Naoki Haratake Naoki Haratake (= 1×) peers Masakazu Katsura

Countries citing papers authored by Naoki Haratake

Since Specialization

Citations

This map shows the geographic impact of Naoki Haratake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Haratake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Haratake more than expected).

Fields of papers citing papers by Naoki Haratake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Haratake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Haratake. The network helps show where Naoki Haratake may publish in the future.

Co-authorship network of co-authors of Naoki Haratake

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Haratake. A scholar is included among the top collaborators of Naoki Haratake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Haratake. Naoki Haratake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shigeta, Keisuke, Hiroshi Hongo, Sheng‐Yu Ku, et al.. (2025). MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy. JCI Insight. 10(14). 1 indexed citations

Haratake, Naoki, Atrayee Bhattacharya, Weipu Mao, et al.. (2024). IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS. Cancer Research Communications. 4(5). 1268–1281. 4 indexed citations

Toyokawa, Gouji, Francesca Bersani, Paolo Bironzo, et al.. (2023). Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications. Critical Reviews in Oncology/Hematology. 184. 103966–103966. 9 indexed citations

Yoneshima, Yasuto, Koji Okamura, Toyoshi Yanagihara, et al.. (2023). MicroRNA‐326 negatively regulates CD155 expression in lung adenocarcinoma. Cancer Science. 114(10). 4101–4113. 4 indexed citations

Tagawa, Tetsuzo, Naoki Haratake, Fumihiko Kinoshita, et al.. (2023). Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma. Cancer Immunology Immunotherapy. 72(6). 1823–1834. 33 indexed citations

Haratake, Naoki, Hiroki Ozawa, Yoshihiro Morimoto, et al.. (2023). Abstract B089: MUC1-C is a common driver of acquired osimertinb resistance in NSCLC. Molecular Cancer Therapeutics. 22(12_Supplement). B089–B089. 2 indexed citations

Masuda, Takaaki, Taro Tobo, Yuta Kobayashi, et al.. (2022). Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma. SSRN Electronic Journal.

Yamashita, Nami, Yoshihiro Morimoto, Atsushi Fushimi, et al.. (2022). MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer. Molecular Cancer Research. 21(3). 274–289. 25 indexed citations

Haratake, Naoki, Tomoyoshi Takenaka, Kenji Watanabe, et al.. (2022). Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma. Thoracic Cancer. 13(18). 2624–2632. 6 indexed citations

10.

Ono, Yuki, Tetsuzo Tagawa, Fumihiko Kinoshita, et al.. (2022). Relationship between consolidation tumor ratio and tumor‐infiltrating lymphocytes in small‐sized lung adenocarcinoma. Thoracic Cancer. 13(15). 2134–2141. 4 indexed citations

11.

Tanaka, Yasushi, Naoki Haratake, Fumihiko Kinoshita, et al.. (2021). Spontaneous hemopneumothorax with a ruptured aneurysm in the second intercostal artery: report of a case. General Thoracic and Cardiovascular Surgery. 69(7). 1133–1136. 1 indexed citations

12.

Shoji, Fumihiro, Takaki Akamine, Fumihiko Kinoshita, et al.. (2021). Preoperative prognostic nutritional index level is associated with tumour-infiltrating lymphocyte status in patients with surgically resected lung squamous cell carcinoma. European Journal of Cardio-Thoracic Surgery. 60(2). 393–401. 15 indexed citations

13.

Takada, Kazuki, Shinkichi Takamori, Taichi Matsubara, et al.. (2020). Clinical significance of preoperative inflammatory markers in non-small cell lung cancer patients: A multicenter retrospective study. PLoS ONE. 15(11). e0241580–e0241580. 12 indexed citations

14.

Takamori, Shinkichi, Gouji Toyokawa, Mototsugu Shimokawa, et al.. (2018). The C-Reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-institutional Study. Annals of Surgical Oncology. 25(6). 1555–1563. 17 indexed citations

15.

Takamori, Shinkichi, Tetsuzo Tagawa, Gouji Toyokawa, et al.. (2018). The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score‐matched analysis. Cancer Medicine. 7(7). 2860–2867. 1 indexed citations

16.

Takamori, Shinkichi, Gouji Toyokawa, Tatsuro Okamoto, et al.. (2018). Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer. Annals of Surgical Oncology. 25(5). 1229–1236. 44 indexed citations

17.

Takamori, Shinkichi, Gouji Toyokawa, Hiroaki Ueo, et al.. (2017). Family-associated factors influence the postoperative prognosis in patients with non-small cell lung cancer. Annals of Oncology. 28. v509–v509. 2 indexed citations

18.

Shoji, Fumihiro, Taichi Matsubara, Yuka Kozuma, et al.. (2017). Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer. Anticancer Research. 37(12). 6997–7003. 38 indexed citations

19.

Matsubara, Taichi, Gouji Toyokawa, Yuichi Yamada, et al.. (2017). A Case of the Resected Lymphohistiocytoid Mesothelioma: BAP1 Is a Key of Accurate Diagnosis. Anticancer Research. 37(12). 6937–6941. 2 indexed citations

20.

Toyokawa, Gouji, Yuka Kozuma, Taichi Matsubara, et al.. (2017). Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma. Journal of Thoracic Disease. 9(9). 2942–2951. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact